ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1171

Diffusion–weighted Magnetic Resonance Imaging (MRI) of Wrist and Hands in Patients with Rheumatoid arthritis  –reproducibility and Correlation with Conventional MRI

Misbah Khurram1, Jakob M. Møller1, Mikkel Østergaard2, Henrik Thomsen1, Bo Jannik Ejbjerg3, Merete Lund Hetland4 and Signe Møller-Bisgaard3,5, 1Department of Radiology, Copenhagen University Hospital Herlev, Copenhagen, Denmark, 2Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Glostrup, Denmark, 3Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark, 4Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Glostrup, Denmark, 5Copenhagen Center for Arthritis Research, Copenhagen University Hospital at Glostrup, Glostrup, Denmark

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: bone marrow lesions and rheumatoid arthritis (RA), MRI

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases: Magnetic Resonance Imaging (MRI)

Session Type: Abstract Submissions (ACR)

.Background/Purpose:

The aim of this study was to investigate the performance of diffusion-weighted imaging (DWI) in detecting high signal intensity areas (HSIA), as potential signs of bone inflammation, in wrist and metacarpophalangeal (MCP) joints of rheumatoid arthritis (RA) patients, in comparison with short tau inversion recovery (STIR) MRI images.

.Methods:

26 patients with RA in clinical remission underwent MRI including DWI (with apparent diffusion coefficient (ADC) maps), T1-weighted (T1w) and STIR images. 13 were rescanned after 4 months. STIR scans were scored for bone marrow edema (BME) according to Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) Rheumatoid Arthritis Magnetic Resonance Imaging scoring system (RAMRIS) and DWI scans were scored for absence (0) or presence (1) of HSIA in bone marrow. STIR and DWI images were reviewed separately by one reader and ADC values were calculated in each of 21 bones in the wrist and MCP joints. For calculation of ADC, regions of interest (ROIs) were drawn, which covered the maximal possible subcortical bone areas, including both areas with high and with normal signal, avoiding erosions (method A). Furthermore, in DWI positive areas, ROIs were also placed within the HSIA (method B). ADC values were divided into 4 groups based on STIR and DWI scores as seen in the table below and nonparametric tests were used to compare groups. The reproducibility of the scores was analyzed by kappa (k) values, intra-class correlation coefficient (ICC), and smallest detectable difference (SDD) and change (SDC).

.Results:

STIR showed more positive lesions (132 HSIA (=bone marrow edema)) than DWI (50 HSIA) (p<0.001 Fisher's exact test). Mean ADC of “STIR-only” (STIR+/DWI-) positive lesions (318±172x10-3 mm2 /s was significantly lower than lesions, where both STIR and DWI were positive (STIR+/DWI+; 894±486×10-3mm2/s) (p<0.001; Mann-Whitney U test). ADC-values increased with increasing STIR scores (see table).The median ADC, in DWI positive areas, with method A (759.5x10-3mm2/s) was slightly lower than the median ADC with method B (846×10-3mm2/s) (p-value 0.048; Wilcoxon signed rank test). There was no statistically significant difference between baseline and 4 months follow-up scans in any parameters (p=0.9, 0.8 and 0.2 for STIR, DWI and ADC respectively; Wilcoxon signed rank test).The intraobserver agreement was good to excellent using STIR (k=0.80) and DWI (k=0.76), respectively (baseline). The intraobserver ICC of ADC measurements was 0.85. Intraobserver SDD of ADC at baseline was 60×10-3mm2/s, whereas intraobserver SDC between baseline and 4 months follow up was 108×10-3mm2/s.

.Conclusion:

DWI, including ADC measurements, in bones of patients with RA were highly reproducible and may partially reflect BME on STIR MRI. Further studies are needed to investigate if the method is useful for monitoring treatment response and/or predicting disease progression.


Disclosure:

M. Khurram,
None;

J. M. Møller,
None;

M. Østergaard,

Abbott/Abbvie, BMS, Boehringer-Ingelheim, Eli-Lilly, Centocor, GSK, Janssen, Merck, Mundipharma, Novo, Pfizer, Schering-Plough, Roche UCB, and Wyeth.,

5,

Abbott/Abbvie, Centocor, Merck, Schering-Plough,

2;

H. Thomsen,
None;

B. J. Ejbjerg,
None;

M. L. Hetland,
None;

S. Møller-Bisgaard,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diffusion-weighted-magnetic-resonance-imaging-mri-of-wrist-and-hands-in-patients-with-rheumatoid-arthritis-reproducibility-and-correlation-with-conventional-mri/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology